Advanced Search:
Equity Index Forex Crypto Commodity

GILD - Gilead Sciences

$68.07  -0.58 (-0.84%)

Updated: 03:10 May 5, 2024 EST

Next Hour's AI Forecast

99.37%

Avg. Accuracy (AI)

$64.15

Next Session's AI Forecast

95.69%

Avg. Accuracy (AI)

$69.81

Next Week's AI Forecast

0%

Trend's Accuracy (AI)

$68.31

Gilead Sciences's Position Within the Drug Manufacturers—General Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

GILEAD SCIENCES - HISTORICAL DATA 6M

  • Last price

    $ 68.07

  • Daily change

    $ -0.58

  • Previous Close

    $ 68.65

  • Last Updated

    03:10 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.07 -0.33 -0.14 -0.09 -0.06

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.71 0.82 0.85 1.02 0.98

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
89.47% 58.62% 17.57% 6.09%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
65.31 -0.64% 65.73 -3.9% 68.4 -9.31% 75.42

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.3 55.56 0.68 23.08

Gilead Sciences Technical Analysis News

Gilead Sciences

333 Lakeside Drive
Foster City, CA 94404
United States
650 574 3000
https://www.gilead.com

Sectors: Healthcare
Industry: Drug Manufacturers—General
F. Time Employees: 18000
Description

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Corporate Governance

Gilead Sciences, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 2. The pillar scores are Audit: 3; Board: 5; Shareholder Rights: 1; Compensation: 4.

GILEAD SCIENCES'S HOLDERS RANK

List of holders with stock participation in Gilead Sciences.

Holder Rank Holder Shares Date Reported % Out Value